Pharmacodynamics, pharmacokinetics and safety of GSK2190915, a novel oral anti-inflammatory 5-lipoxygenase-activating protein inhibitor

  • Pharmacokinetics, pharmacodynamics and safety of the FLAP inhibitor, GSK2190915
  • Gretchen Bain, Christopher D. King, Kevin Schaab, Melissa Rewolinski, Virginia Norris, Claire Ambery, Jane Bentley, Masanori Yamada, Angelina M. Santini, Jeroen van de Wetering de Rooij, Nicholas Stock, Jasmine Zunic, John H. Hutchinson, Jilly F. Evans
  • British Journal of Clinical Pharmacology, February 2013, Wiley
  • DOI: 10.1111/j.1365-2125.2012.04386.x

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1111/j.1365-2125.2012.04386.x

In partnership with:

Link to Wiley showcase